Related Experiment Video
Updated: Sep 1, 2025
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
The Correlation Between MicroRNAs and Diabetic Retinopathy
Xin Zhao1, Feng Ling1, Guang Wei Zhang2
1Department of Ophthalmology, Inner Mongolia Baogang Hospita, Baotou, Inner Mongolia, China.
Abstract:
Micro ribonucleic acids (miRNAs), as a category of post-transcriptional gene inhibitors, have a wide range of biological functions, are involved in many pathological processes, and are attractive therapeutic targets. Considerable evidence in ophthalmology indicates that miRNAs play an important role in diabetic retinopathy (DR), especially in inflammation, oxidative stress, and neurodegeneration. Targeting specific miRNAs for the treatment of DR has attracted much attention. This is a review focusing on the pathophysiological roles of miRNAs in DR, diabetic macular edema, and proliferative DR complex multifactorial retinal diseases, with particular emphasis on how miRNAs regulate complex molecular pathways and underlying pathomechanisms. Moreover, the future development potential and application limitations of therapy that targets specific miRNAs for DR are discussed.
Insights
Micro ribonucleic acids (miRNAs) are key regulators in diabetic retinopathy (DR). This review explores their role in DR
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Micro ribonucleic acids (miRNAs) are post-transcriptional gene inhibitors with diverse biological functions.
- miRNAs are implicated in numerous pathological processes, making them promising therapeutic targets.
- In ophthalmology, miRNAs are increasingly recognized for their critical roles in diabetic retinopathy (DR).
Purpose of the Study:
- To review the pathophysiological roles of miRNAs in diabetic retinopathy (DR).
- To emphasize how miRNAs regulate molecular pathways in DR, diabetic macular edema, and proliferative DR.
- To discuss the therapeutic potential and limitations of targeting miRNAs for DR treatment.
Main Methods:
- Literature review of existing research on miRNAs in diabetic retinopathy.
- Analysis of molecular pathways regulated by miRNAs in retinal diseases.
- Evaluation of therapeutic strategies targeting miRNAs for DR.
Main Results:
- miRNAs significantly influence inflammation, oxidative stress, and neurodegeneration in DR.
- Specific miRNAs modulate complex molecular pathways underlying DR pathogenesis.
- Targeting miRNAs presents a potential therapeutic avenue for DR.
Conclusions:
- miRNAs are crucial players in the pathogenesis of diabetic retinopathy.
- Understanding miRNA regulation offers insights into DR mechanisms.
- Therapeutic strategies targeting miRNAs show promise but require further investigation for DR treatment.
More Related Videos
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
